Literature DB >> 29270746

Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.

Xiong Cai1, Jun Xiong1, Qing-Gang Hu1, Qiu-Dong Zhao2, Dong Wu3, Li-Gong Tang4, Chi-Dan Wan5, Li-Xin Wei6.   

Abstract

Combined hepatocellular-cholangiocarcinoma (CHC) is a mixed tumor containing elements of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell (HPC) origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7 (K7) staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the "transitional" cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of "stemness" by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.

Entities:  

Keywords:  cholangiohepatoma; heterogeneity; histology; human; progenitor

Mesh:

Substances:

Year:  2017        PMID: 29270746     DOI: 10.1007/s11596-017-1820-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  27 in total

1.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.

Authors:  Mina Komuta; Bart Spee; Sara Vander Borght; Rita De Vos; Chris Verslype; Raymond Aerts; Hirohisa Yano; Tetsuya Suzuki; Masanori Matsuda; Hideki Fujii; Valeer J Desmet; Masamichi Kojiro; Tania Roskams
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

2.  Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.

Authors:  Z D Goodman; K G Ishak; J M Langloss; I A Sesterhenn; L Rabin
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

3.  Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.

Authors:  Xiong Cai; Jian Zhai; David E Kaplan; Yijun Zhang; Lining Zhou; Xutao Chen; Guangyang Qian; Qiudong Zhao; Yonghai Li; Lu Gao; Wenming Cong; Minghua Zhu; Zhenlin Yan; Lehua Shi; Dong Wu; Lixin Wei; Feng Shen; Mengchao Wu
Journal:  Hepatology       Date:  2012-06-25       Impact factor: 17.425

4.  A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.

Authors:  Jae Yeon Seok; Deuk Chae Na; Hyun Goo Woo; Massimo Roncalli; So Mee Kwon; Jeong Eun Yoo; Ei Yong Ahn; Gwang Il Kim; Jin-Sub Choi; Young Bae Kim; Young Nyun Park
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 5.  Colorectal cancer stem cells: from the crypt to the clinic.

Authors:  Ann Zeuner; Matilde Todaro; Giorgio Stassi; Ruggero De Maria
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

6.  Hepatic 'stem cell' malignancies in adults: four cases.

Authors:  N D Theise; J L Yao; K Harada; P Hytiroglou; B Portmann; S N Thung; W Tsui; H Ohta; Y Nakanuma
Journal:  Histopathology       Date:  2003-09       Impact factor: 5.087

7.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

8.  Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.

Authors:  F Zhang; X-P Chen; W Zhang; H-H Dong; S Xiang; W-G Zhang; B-X Zhang
Journal:  Histopathology       Date:  2008-01       Impact factor: 5.087

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.

Authors:  Tsunekazu Oikawa; Eliane Wauthier; Timothy A Dinh; Sara R Selitsky; Andrea Reyna-Neyra; Guido Carpino; Ronald Levine; Vincenzo Cardinale; David Klimstra; Eugenio Gaudio; Domenico Alvaro; Nancy Carrasco; Praveen Sethupathy; Lola M Reid
Journal:  Nat Commun       Date:  2015-10-06       Impact factor: 14.919

View more
  1 in total

1.  Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features.

Authors:  Xiong Cai; Heli Li; David E Kaplan
Journal:  Cell Biosci       Date:  2020-03-13       Impact factor: 7.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.